• Call(WhatsApp Us)

    +8615360806100
  • Email Us

    cherry@laeyo.com
  • 广州市花都区花山镇华辉路18号

    微观化妆品创意产业园E栋整栋

Wrong Skincare Label Version on Delivered Stock: Who Handles Rework and Replacement?

You approved artwork revision C. The pallet that arrived carries revision B — or the label is current, but the INCI list still reflects the formula from before the preservative swap. Before anyone argues…

Category: Body Care Sourcing Guides • Author: laeyo • Published: 2026-11-17 • Views: 4

You approved artwork revision C. The pallet that arrived carries revision B — or the label is current, but the INCI list still reflects the formula from before the preservative swap. Before anyone argues about money, one technical question has to be settled: is this a cosmetic-only mismatch, or a regulatory defect that makes the delivered stock unsaleable in your target market? That answer determines who owns the rework, who pays for replacement stock, and how fast you can get back into the channel. This guide covers triage in the first 72 hours, cost allocation by root cause, rework options and their hidden risks, and the documentary evidence a body care brand should request before accepting any corrected delivery.

First, classify the defect — not the inconvenience

In a functioning quality system, a wrong label or wrong artwork on finished goods is a critical defect, not a cosmetic one. It sits in the same category as a mix-up in product identity, because the label is what tells the user what the product is, how to use it, and what is inside it. Typical acceptance criteria for this defect class are project-defined and usually set at zero defects — meaning “we will sort it at the warehouse” is not an acceptable disposition.

Label “versions” fail along several independent dimensions. Most disputes happen because buyer and factory are each talking about a different dimension.

Version dimension Typical mismatch Consequence if missed
Artwork revision (label, box, sleeve) Rev C approved, Rev B printed Identity and claims risk; may ship unsubstantiated copy
Formula / INCI version Label reflects F1, bulk made to F2 Ingredient declaration does not match the product — regulatory defect
Market pack One pack shipped to two markets with different mandatory statements Product not compliant for the destination market; cannot be sold as-is
Claims version Copy from an older claims library still in print Claim on pack has no supporting file behind it
Coding (batch, PAO, expiry) Code applied to the wrong panel or omitted Traceability and recall capability broken
SKU / variant Correct label, wrong scent or size on the line Wrong product enters the channel; returns and listing risk

The first 72 hours: quarantine, then reconstruct the record

Do not ship, do not discount, and do not let the factory talk you into “sell through and we fix the next run.” Work in this order:

  • Quarantine and photograph. Hold the affected pallets physically and in your ERP/WMS. Photograph the full label, the batch code, the carton markings, and the pallet label together in one frame.
  • Pull the approved artwork record. Identify the exact approved revision, the sign-off date, the approver, and the file hash or PDF version that was released to the printer.
  • Request the traceability chain for the finished batch. The finished batch number should link to the SKU, bulk batch, formula version, process version, production line, raw material lots, packaging material lots, QC results, and micro results. The packaging material lot is the single most useful field here — it tells you which label revision physically entered the line and when.
  • Compare against the retention sample. Approved retention samples and the golden sample settle arguments about “what was actually agreed” faster than email threads.
  • Decide whether the stock is legally blocked or merely wrong. Aesthetic or brand-identity mismatch can sometimes be reworked and released. An INCI mismatch, a missing mandatory statement, or an unsubstantiated claim on pack usually cannot.

Who handles rework and replacement: allocate by root cause, not by who noticed

Most supplier agreements are silent on label-version errors, which is why these disputes drag. The cleanest resolution is to allocate cost by the party whose process failed, and to separate rework labour from replacement stock and freight — they rarely belong to the same party.

Scenario Root-cause owner Rework labour Replacement stock + freight Evidence to close the case
Factory applied a superseded revision after the approved proof was released Manufacturer Manufacturer Manufacturer (or credit note) Approved artwork release record vs. packaging lot used on the batch
Buyer approved the wrong file, or changed artwork after print started Buyer Buyer Buyer, plus any scrap and expedite fees Signed approval dated after the print release; change-order record
Label converter printed the wrong revision to an approved spec Packaging supplier Split by agreement Packaging supplier Print approval proof, plate/sleeve records, incoming inspection of the label lot
Regulatory or claims change made the pack non-compliant mid-production Shared / commercial negotiation Buyer Buyer, unless label stock was not yet consumed Date of the regulatory change vs. date of print release
Correct label, wrong variant or size applied on the line Manufacturer Manufacturer Manufacturer Line clearance records, reconciliation of label issue vs. consumption

Two clauses do most of the work in preventing an argument: (1) the approved artwork revision is referenced by code and date in the purchase order, and (2) label/artwork errors are named as critical defects with a defined remedy — rework, replacement, or credit — triggered on discovery rather than on negotiation.

Rework options — and what each one quietly risks

“Just overlabel it” is the fastest and most commonly oversold fix. It is also the option that most often creates a second problem.

  • Overlabeling. Workable only if the correction covers the defective panel completely, the new label adheres to the existing surface without lifting, and the batch code, PAO and expiry remain legible and unaltered. Never overlabel over a coding panel.
  • Label removal and relabel. Requires a residue and surface check: adhesive residue, fibre lift on cartons, solvent attack on printed bottles. Ask for a compatibility note or a short adhesion trial on the actual container lot, not a generic label stock.
  • Reprint and replace. Cleanest from a compliance standpoint, slowest on supply. Confirm print lead time and whether the container can be reworked without damage; shrink sleeves and tamper bands are usually single-use.
  • Scrap and rebuild. Sometimes the cheapest real answer when the bulk is still compliant — retain the bulk, destroy the labelled units, relabel from bulk. Confirm the bulk’s remaining shelf life and re-test requirements before committing.

One caution on the last option: if the correction involves changing the container or closure, treat it as a packaging change, not a labelling change. Stability and preservative challenge results are valid only for the specific formula, preservative system, fragrance version and package they were run on — any change to formula or package should trigger a documented re-test assessment, even if the outcome is “no re-test required.”

Evidence to request before you sign off on the corrected delivery

  • Request: the batch traceability record for the reworked lot.
    Evidence: finished batch, bulk batch, formula version, process version, line, raw material lots, packaging material lots, QC results, micro results — all linked.
    Acceptance criteria: the new packaging lot is traceable to the corrected label revision, and no finished unit carries the superseded lot.
  • Request: incoming inspection record for the corrected label lot.
    Evidence: signed incoming check against the approved artwork (revision code, barcode scan, mandatory statements, market version).
    Acceptance criteria: zero discrepancies on identity, INCI, and mandatory statements.
  • Request: line clearance and label reconciliation for the rework run.
    Evidence: labels issued vs. consumed vs. destroyed, with the destruction witnessed.
    Acceptance criteria: balance accounts for 100% of the superseded label stock.
  • Request: updated label proof pack aligned to the current formula and claims.
    Evidence: label artwork, INCI matching the current formula version, allergen declaration per the current fragrance documentation, and a claims-to-substantiation map.
    Acceptance criteria: every on-pack claim traces to a document in the claims file; no orphan claims.
  • Request: retention samples from the reworked batch.
    Evidence: retained units stored under approved conditions, plus the golden sample reference.
    Acceptance criteria: retention sample matches the approved reference for label and appearance.
  • Request: a short deviation/CAPA report.
    Evidence: root cause, containment, corrective action, and the change to the artwork release or line-clearance procedure.
    Acceptance criteria: the corrective action names a specific control, an owner, and a verification date.

Preventing version drift on the next purchase order

  • Freeze the artwork revision in writing. The PO should cite the artwork code, revision, and approval date — not “current label.”
  • Keep one controlled label-version register covering artwork revision, formula version, market pack, and claims version, with a single named approver per market.
  • Treat fragrance and preservative changes as label triggers. A supplier change can alter the allergen declaration and the warnings panel; it can also change the safety file. Re-issue the label pack and re-check the documentation together.
  • Never translate claims freely. Marketing copy that upgrades “repair” or “nourish” into a medical or growth mechanism should be blocked at the claims library, not caught at the printer.
  • Run a first-article check on every print run before full production: revision code, barcode, INCI, mandatory statements, batch/PAO panel position.

Planning timelines (confirm with your manufacturer)

  • Root-cause confirmation and disposition decision: typically 2–5 business days once the traceability record and approved artwork are in hand.
  • Overlabel or relabel on existing stock: commonly 5–10 business days including re-inspection, longer if the label must be reprinted.
  • Reprint plus full relabel from bulk: plan on 2–4 weeks depending on print lead time and line availability.
  • Scrap and rebuild: add bulk re-testing and a new production slot; treat as a new run with its own documentation handoff.

Informational only, not legal advice. Market-specific labelling and claim requirements should be confirmed with your regulatory responsible person or specialist counsel for each destination market.

FAQ

Can we simply overlabel the delivered stock and ship it?

Only if the correction fully covers the defective panel, the new label adheres reliably to that specific container, and the batch code, PAO and expiry remain legible and untouched. If the underlying problem is an INCI mismatch or a missing mandatory statement, overlabeling may fix the surface but not the compliance question — the label still has to match the formula version actually produced.

Who pays if we approved the wrong proof?

The buyer normally absorbs rework labour, scrap and any expedite cost, because the release record shows the buyer approved the file that was printed. This is why approval should always be tied to a specific revision code and date rather than a filename or an email attachment.

Does relabeling invalidate our stability or preservative testing?

Relabeling alone does not. Changing the container, closure or label system in a way that affects the product-packaging interface should trigger a documented re-test assessment — stability and preservative challenge results are only valid for the formula, preservative system, fragrance version and package they were run on. If the fix is a label system change, ask for a compatibility note on adhesion and migration.

What if a regulatory or claims change landed mid-production?

Compare the effective date of the change against the date the artwork was released for print. If the print release predates the change, the stock is usually a commercial negotiation; if it postdates it, the party that released the artwork owns the rework. Either way, do not let the fix stop at the label — re-check the formula, the evidence file and the notification documentation together.

How do we stop this recurring?

Three controls cover most of the risk: a single controlled label-version register with one approver per market, a PO that cites the exact artwork revision, and a first-article check against the approved proof before every print run goes to full production.

Next step

If you are dealing with a delivered batch that carries the wrong label version — or you want a label-version and claims-control process built into your next body care run — send us the target market, SKU and format, positioning, packaging direction and timeline target. That information is what turns a quotation into a specific, checkable plan.

Request a Quote

Hi, I'm your LAEYO representative, hope you like this blog post.

With more than 20 years of experience in OEM/ODM/Private Label Cosmetics, I'd love to share valuable knowledge related to cosmetics & skincare products from a top-tier Chinese supplier's perspective.

  • Our team will answer your inquiries within 8 hours.
  • Your information will be kept strictly confidential.

Request received

Thanks — we’ve received your request. Our team will follow up shortly. we typically reply within 8 hours (often sooner).